Comparative effectiveness of direct oral anticoagulants and warfarin in patients with cancer and atrial fibrillation

Timp, 2013, Epidemiology of cancer-associated venous thrombosis, Blood, 122, 1712, 10.1182/blood-2013-04-460121 Prandoni, 2002, Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis, Blood, 100, 3484, 10.1182/blood-2002-01-0108 Connolly, 2009, Dabigatran versus warfarin in patients with atrial fibrillation, N Engl J Med, 361, 1139, 10.1056/NEJMoa0905561 Patel, 2011, Rivaroxaban versus warfarin in nonvalvular atrial fibrillation, N Engl J Med, 365, 883, 10.1056/NEJMoa1009638 Granger, 2011, Apixaban versus warfarin in patients with atrial fibrillation, N Engl J Med, 365, 981, 10.1056/NEJMoa1107039 Giugliano, 2013, Edoxaban versus warfarin in patients with atrial fibrillation, N Engl J Med, 369, 2093, 10.1056/NEJMoa1310907 Lee, 2013, Treatment of cancer-associated thrombosis, Blood, 122, 2310, 10.1182/blood-2013-04-460162 Hendrie, 2013, Are new oral anticoagulants ready for use in patients with cancer?, J Natl Compr Canc Netw, 11, 1446, 10.6004/jnccn.2013.0165 Lyman, 2015, Venous thromboembolism prophylaxis and treatment in patients with cancer: american society of clinical oncology clinical practice guideline update 2014, J Clin Oncol, 33, 654, 10.1200/JCO.2014.59.7351 Hansen LG , ChangS. Health research data for the real world: the MarketScan databases. http://truvenhealth.com/portals/0/assets/PH_11238_0612_TEMP_MarketScan_WP_FINAL.pdf. Accessed 18 June 2017. Jensen, 2012, A systematic review of validated methods for identifying atrial fibrillation using administrative data, Pharmacoepidemiol Drug Saf, 21, 141, 10.1002/pds.2317 Garg, 2011, Ascertainment of warfarin and aspirin use by medical record review compared with automated pharmacy data, Pharmacoepidemiol Drug Saf, 20, 313, 10.1002/pds.2041 Mayo Clinic. Locally written SAS macros: gmatch macro. http://www.mayo.edu/research/departments-divisions/department-health-sciences-research/division-biomedical-statistics-informatics/software/locally-written-sas-macros. Accessed 18 June 2017. Andrade, 2012, A systematic review of validated methods for identifying cerebrovascular accident or transient ischemic attack using administrative data, Pharmacoepidemiol Drug Saf, 21, 100, 10.1002/pds.2312 Cunningham, 2011, An automated database case definition for serious bleeding related to oral anticoagulant use, Pharmacoepidemiol Drug Saf, 20, 560, 10.1002/pds.2109 Wahl, 2010, Validation of claims-based diagnostic and procedure codes for cardiovascular and gastrointestinal serious adverse events in a commercially-insured population, Pharmacoepidemiol Drug Saf, 19, 596, 10.1002/pds.1924 Cushman, 2004, Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology, Am J Med, 117, 19, 10.1016/j.amjmed.2004.01.018 White, 1998, Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California, Ann Intern Med, 128, 737, 10.7326/0003-4819-128-9-199805010-00006 Heckbert, 2004, Comparison of self-report, hospital discharge codes, and adjudication of cardiovascular events in the Women’s Health Initiative, Am J Epidemiol, 160, 1152, 10.1093/aje/kwh314 Kniffin, 1994, The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly, Arch Intern Med, 154, 861, 10.1001/archinte.1994.00420080053005 Dombkowski, 2009, Asthma surveillance using Medicaid administrative data: a call for a national framework, J Public Health Manag Pract, 15, 485, 10.1097/PHH.0b013e3181a8c334 Quan, 2005, Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data, Med Care, 43, 1130, 10.1097/01.mlr.0000182534.19832.83 Lip, 2010, Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial Fibrillation, Chest, 137, 263, 10.1378/chest.09-1584 Schneeweiss, 2009, High-dimensional propensity score adjustment in studies of treatment effects using health care claims data, Epidemiology, 20, 512, 10.1097/EDE.0b013e3181a663cc Rassen, 2011, Covariate selection in high-dimensional propensity score analyses of treatment effects in small samples, Am J Epidemiol, 173, 1404, 10.1093/aje/kwr001 Benjamin, 2017, Heart disease and stroke statistics-2017 update: a report from the American Heart Association [published corrections appear in Circulation. 2017;135(10):e646 and 2017;136(10):e196], Circulation, 135, e146 Farmakis, 2014, Insights into onco-cardiology: atrial fibrillation in cancer, J Am Coll Cardiol, 63, 945, 10.1016/j.jacc.2013.11.026 Khorana, 2007, Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy, J Thromb Haemost, 5, 632, 10.1111/j.1538-7836.2007.02374.x Agnelli, 2015, Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial, J Thromb Haemost, 13, 2187, 10.1111/jth.13153 Sardar, 2015, New oral anticoagulants in patients with cancer: current state of evidence, Am J Ther, 22, 460, 10.1097/MJT.0000000000000055 Streiff, 2016, Thrombosis in the setting of cancer, Hematology Am Soc Hematol Educ Program, 2016, 196, 10.1182/asheducation-2016.1.196